๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Antibody expression in bacteriophage systems: The future of monoclonal antibodies?

โœ Scribed by Lisa J. Garrard; Eugene A. Zhukovsky

Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
772 KB
Volume
3
Category
Article
ISSN
0958-1669

No coin nor oath required. For personal study only.

โœฆ Synopsis

Bacteriophage systems have been utilized to express and isolate antibodies. This promising technology has been evolving rapidly and has the potential to revolutionize the way in which monoclonal antibodies are generated. This review focuses on the many recent advances that have been made in obtaining monoclonal antibodies from bacteriophage systems.

๐Ÿ“œ SIMILAR VOLUMES

Monoclonal antibody drug conjugates in t
Monoclonal antibody drug conjugates in the treatment of cancer
โœ Pamela A Trail; Albert B Bianchi ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 79 KB

Monoclonal antibodies directed to tumor-associated antigens have been chemically conjugated to drugs with different mechanisms of action and different levels of potency. Monoclonal-antibody-directed drug delivery has the potential to both improve efficacy and reduce systemic toxicity. Several immuno

Advances in the management of psoriasis:
Advances in the management of psoriasis: monoclonal antibody therapies
โœ Don Mehrabi; Joshua B. DiCarlo; Seaver L. Soon; Calvin O. McCall ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 157 KB

## Abstract Psoriasis is a common skin disorder characterized by erythematous, scaling plaques. Until recently, therapies for this disease have been aimed at reducing keratinocyte proliferation. We have learned that psoriasis is not primarily a disorder of keratinocyte hyperproliferation, but is an